Skip to content

Medical-device intelligence

GFO: Activated Partial Thromboplastin

FDA product code GFO: Activated Partial Thromboplastin. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
GFO
FDA device name
Activated Partial Thromboplastin
Device class
2
Regulation number
864.7925
Medical specialty
Hematology
Review panel
HE

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

52 clearance records and 10 recall records in the covered releases, across 37 source company names and 1 product codes. Dated history runs from Aug 3, 1976 to Jan 9, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202501
December 202501
January 202610
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
GFO · Activated Partial Thromboplastin5210

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

62 matching records
Device / recordCompany in FDA recordSourceSource date
THROMBOSCREEN APTT REAGENTK891337 · GFOPacific Hemostasis510(k)Apr 21, 1989FDA decision date
EDL ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENTK890619 · GFOElite Diagnostic , Ltd.510(k)Mar 15, 1989FDA decision date
BIOTRACK APTT REAGENT CARTRIDGEK890052 · GFOBiotrack, Inc.510(k)Feb 24, 1989FDA decision date
APTT REAGENTK884856 · GFOPrecision Biologicals, Inc.510(k)Jan 30, 1989FDA decision date
EASY-TEST PARTIAL THROMBOPLASTIN TIME PTT #16629K884702 · GFOEm Diagnostic Systems, Inc.510(k)Jan 27, 1989FDA decision date
KD ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENTK884485 · GFOKing Diagnostics, Inc.510(k)Dec 28, 1988FDA decision date
UNIFAST ACTIVATED PARTIAL THROMBOPLASTIN TIME TESTK882325 · GFOSclavo, Inc.510(k)Aug 25, 1988FDA decision date
CLP ACTIVATED PARTIAL THROMBOPLASTIN TIME TESTK881068 · GFOCreative Laboratory Products, Inc.510(k)Mar 23, 1988FDA decision date
ALUMINA SILICA-ACTIVATED PARTIAL THROMK820835 · GFOHyland Therapeutic Div., Travenol Laboratories510(k)Apr 26, 1982FDA decision date
PLASMA COAGULATION CONT., ABNORMALK781104 · GFOOrtho Diagnostics, Inc.510(k)Aug 10, 1978FDA decision date
HEPARIN CONTROL PLASMAK760918 · GFOHyland Therapeutic Div., Travenol Laboratories510(k)Jan 10, 1977FDA decision date
ACTIN, ACTIVATED CEPHALOPLASTIN REAGENTK760318 · GFODade, Baxter Travenol Diagnostics, Inc.510(k)Aug 3, 1976FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗